Düsseldorf || 16 - 19 November 2026

PixCell Medical

The most intuitive 5-part differential CBC analyzer FDA-cleared for Point of Care

Company status: Established
Company profile

Solution at a glance

PixCell Medical, an innovator of hematology diagnostics at the point of care, has developed the most intuitive 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared and CE-marked for point-of-care use – the HemoScreen™. This portable, easy-to-use platform offers clinically proven lab-accurate readings of 20 standard blood count parameters within five minutes, with just one finger-prick of blood. Leveraging a cutting-edge disposable cartridge preloaded with all necessary reagents, HemoScreen’s unique AI-powered Viscoelastic Focusing technology enables improved medical outcomes and patient quality of life while substantially simplifying the workflow and reducing costs for healthcare providers.
Meet us at MEDICA 2026

Guy Frak

CCO
Düsseldorf · 16 – 19 November 2026 · Israel Pavilion

Ready to expand globally?